Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 6/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | LIPE | Q05469 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | XBP1 | P17861 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8635319 | 0.83 | RAB9A (0.66) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL11196331 | 0.83 | SMN1; SMN2 (0.67) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL5592490 | 0.82 | CYP1A2 (0.55) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL1153348 | 0.82 | LMNA (0.58) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL8304598 | 0.80 | CYP1A2 (0.56) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL3751730 | 0.80 | CYP1A2 (0.56) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL16638539 | 0.78 | CYP1A2 (0.60) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL11360493 | 0.77 | SMN1; SMN2 (0.71) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL11269306 | 0.77 | CYP1A2 (0.63) | CYP1A2CYP3A4CYP2C19HPGDRAB9A | |
| SCHEMBL8636194 | 0.77 | SMN1; SMN2 (0.51) | CYP1A2CYP3A4CYP2C19HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426631-B2 | Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same | BASF SE (DE) | 2013-04-23 | — | — | US | disclosed |
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | BASF SE (DE) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | CYP51A1, ERG28, CAT | CYP1A2 22/4885CYP3A4 55/4885CYP2C19 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.